Biodesix, Inc. BDSX Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Operating margin | -26%+17.8pp | -31.5%+16.9pp | -40.6%+12.4pp | -44.5%+10.1pp | -43.8%+21.8pp | |
| Net margin | -33.3%+21.0pp | -39.8%+20.3pp | -49.3%+17.5pp | -53.7%+19.4pp | -54.3%+31.5pp | |
| EBITDA margin | -20.1%+15.9pp | -25.1%+15.2pp | -33.5%+11.4pp | -36.9%+10.2pp | -36%+22.4pp | |
| Free cash flow margin | -26.8%+33.6pp | -27.4%+45.4pp | -36.4%+58.5pp | -40.7%+59.5pp | -60.4%+23.4pp | |
| Returns | ||||||
| Return on assets | -35.3%+11.3pp | -38.2%+5.5pp | -41.3%+4.9pp | -40.4%+5.7pp | -46.6%+9.4pp | |
| Return on invested capital | -45%+20.3pp | -51.6%+20.6pp | -57.6%+21.5pp | -63%— | -65.3%— | |
| Efficiency | ||||||
| Asset turnover | 1.1×+0.2× | 1×+0.2× | 0.8×+0.1× | 0.8×+0.1× | 0.9×+0.2× | |
| Liquidity | ||||||
| Current ratio | 2.8×+0.6× | 1.9×-0.9× | 1.8×-1.6× | 2.1×-1.1× | 2.2×+1.3× | |
| Quick ratio | 2.8×+0.6× | 1.9×-0.9× | 1.8×-1.6× | 2.1×-1.1× | 2.2×+1.3× | |
| Cash ratio | 1.8×+0.4× | 1.1×-0.7× | 0.9×-1.5× | 1.4×-1.0× | 1.3×+1.0× | |
| Leverage | ||||||
| Debt-to-assets | 0.8×0.0× | 0.8×+0.2× | 0.8×+0.2× | 0.8×+0.3× | 0.7×0.0× | |
| Interest coverage | -3.1×+1.3× | -3.6×+0.6× | -4.4×-0.5× | -4.6×-1.0× | -4.4×-0.7× | |
| Per Share | ||||||
| Book value per share | $0.95-37.6% | -$0.33-110% | -$0.23-106% | $0.01-97.3% | $1.52+2,777% | |
| Valuation | ||||||
| Market capitalization | $233.52M+476% | $54.1M-75.7% | $60.4M-76.8% | $40.33M-79.3% | $91.27M-34.3% | |
| Enterprise value | $279.56M+204% | $107.96M-58.2% | $116.71M-59.9% | $91.73M-57.1% | $135.93M-27.9% | |
| Price / sales | 2.4×+1.9× | 0.6×-2.5× | 0.8×-3.2× | 0.5×-2.7× | 1.2×-1.3× | |
| EV / sales | 2.9×+1.7× | 1.2×-2.4× | 1.5×-3.0× | 1.2×-2.3× | 1.8×-1.6× | |
| Free cash flow yield | -11%+65.7pp | -44.8%-21.5pp | -48.3%-24.4pp | -77.2%-45.8pp | -49.3%-16.2pp | |
| Earnings yield | -13.7%+87.6pp | -65.2%-45.9pp | -65.5%-48.6pp | -101.8%-79.0pp | -44.3%-10.4pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Biodesix, Inc.'s ratios come from?
- Every ratio is computed from Biodesix, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
